1 Matching Annotations
- May 2016
that doesn't mean the drugs can't be immensely profitable. Treanda is an orphan drug but also Teva's second-best seller, racking up $740 million in sales last year, according to Teva's annual report.
Isn't the whole point of an orphan drug classification that of limited commercial viability? So if they're not commercially viable how are they profitable?